Baker & Eastlack Ventures

OcuDoc, Inc., based in Columbus, Ohio, is a MedTech startup specializing in innovative eye care technologies. The company has developed OcuDoc Mobile, a pioneering smartphone application that offers accurate and rapid autorefraction and Telerefraction without requiring additional equipment. This platform allows for precise measurement of refractive errors and eye alignment, significantly enhancing the accuracy and efficiency of eye examinations conducted by optometrists. Through its advancements in vision diagnostics, OcuDoc aims to improve the overall eye care experience for both practitioners and patients.

MatriSys Bioscience, Inc. is a clinical stage biopharmaceutical company focused on developing microbiome therapies specifically for dermatology and skin care. Headquartered in La Jolla, California, the company offers its lead product, MSB-01, a topical antimicrobial live bio therapeutic aimed at treating atopic dermatitis by restoring the necessary skin bacteria for effective host defense. In addition to therapeutics, MatriSys develops cosmetic ingredients derived from proprietary bacterial strains to address various skin conditions, including scaling, redness, and signs of aging. The company is exploring commercialization avenues across dermatology, skin care, and cosmetic sectors, with its lead therapeutic currently undergoing Phase I/II clinical trials. MatriSys aims to enhance skin health by rebalancing the skin's microbiome, promoting beneficial microbes while targeting harmful species.

Zerigo Health, formerly known as Clarify Medical, Inc., specializes in home therapy solutions for chronic skin conditions such as psoriasis, eczema, and vitiligo. The company offers innovative products like the Clarify mobile ultra violet B treatment system and the Home Light Therapy System, both designed to facilitate phototherapy in a home setting. Zerigo Health aims to enhance the ease and effectiveness of UVB therapy through a connected system that allows patients to manage their treatment via a smartphone app. This app enables users to control dosing, frequency, and duration of therapy, ensuring adherence to guidelines set by dermatology experts. By allowing patients to administer their treatments with clinical precision, Zerigo Health improves the overall patient experience, while also monitoring compliance and progress, ultimately empowering individuals to manage their chronic skin conditions more effectively from the comfort of their homes.

Lentechs is a medical device company based in Columbus, Ohio, specializing in the development of innovative soft bifocal contact lenses. The company focuses on creating a new generation of soft, suspended progressive contact lenses that enhance visual clarity and comfort. These lenses are designed to allow natural eye movement, similar to the experience of wearing bifocal glasses, while minimizing irritation. Lentechs aims to provide a comprehensive range of products that address the needs of patients throughout their visual health journey.

Neurvana Medical LLC, founded in 2016 and based in Tustin, California, specializes in the design, development, and commercialization of neurovascular therapeutic devices. The company is committed to creating innovative solutions aimed at achieving superior clinical outcomes for patients. Neurvana Medical focuses on delivering high-quality devices that enhance the standard of care in neurovascular treatments, ultimately benefiting patients and healthcare providers alike.

UroDev Medical is focused on designing innovative medical devices to enhance the quality of life for individuals with spinal cord injuries and diseases. The company's flagship product, The Connected Catheter, introduces a semi-permanent, minimally-invasive smart catheter system that measures bladder pressure and wirelessly transmits data to a smartphone. This technology aims to simplify bladder management for millions of users by eliminating the need for intermittent catheters and drainage bags. The system allows both users and clinicians to control a valve that facilitates the emptying of urine from the bladder into the catheter, thereby improving overall bladder care and user experience.

Kurin is a privately held, certified minority-owned business focused on improving healthcare through innovative medical technologies. The company aims to address the issue of false positive blood cultures, which can lead to unnecessary treatments and costs. Kurin has developed blood collection sets that allow for the management of risk associated with nursing protocols by sidelining the specimen before the test sample is collected. This approach significantly reduces the likelihood of contamination, offering a more reliable alternative to standard practices. Building on its previous success with the Curos disinfecting port protectors, Kurin leverages its expertise in medical device engineering, marketing, and sales to enhance caregiver acceptance and establish its Kurin Lock technology as the new standard of care in hospitals.